Xeloda Improves Survival For Early-Stage, HER2-Negative Disease

Options
Moderators
Moderators Member Posts: 25,912
edited June 2017 in Triple-Negative Breast Cancer

Xeloda Improves Survival in Women With Early-Stage, HER2-Negative Disease Who Have Residual Disease After Chemotherapy Before Surgery
June 14, 2017
A study offers more evidence that Xeloda improves both disease-free and overall survival in women diagnosed with early-stage, HER2-negative disease who have residual disease after neoadjuvant chemotherapy. Read more...

· Share on FacebookShare on Twitter

Comments

  • stephilosphy00
    stephilosphy00 Member Posts: 386
    edited June 2017

    Yes, that's why my oncologist wants me to have a few cycles of Xeloda after radiation, I am happy to take it.

    · Share on FacebookShare on Twitter
  • Paisleyskies
    Paisleyskies Member Posts: 24
    edited June 2017

    That is wonderful news. I just finished 8 rounds, 6 months of the stuff!!! It is very doable. No one wants to do a total of 24 rounds of chemo but I am so thankful that my oncologist prescribed it. Anything to increase my chances of seeing my toddler grow up!!

    · Share on FacebookShare on Twitter

Categories